Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Infanta Leonor University Hospital joined the RESILIENCE project in September and with its participation in this clinical trial we continue to grow with the aim of providing a higher quality of life to patients who have overcome cancer, with the reduction of possible cardiac complications due to oncological treatment. The Infanta Leonor University Hospital is […]
